Stathis Argyriou, John F Fullard, Josh M Krivinko, Donghoon Lee, Thomas S Wingo, Aliza P Wingo, Robert A Sweet, Panos Roussos
{"title":"Beyond memory impairment: the complex phenotypic landscape of Alzheimer's disease.","authors":"Stathis Argyriou, John F Fullard, Josh M Krivinko, Donghoon Lee, Thomas S Wingo, Aliza P Wingo, Robert A Sweet, Panos Roussos","doi":"10.1016/j.molmed.2024.04.016","DOIUrl":null,"url":null,"abstract":"<p><p>Neuropsychiatric symptoms (NPSs) in Alzheimer's disease (AD) constitute multifaceted behavioral manifestations that reflect processes of emotional regulation, thinking, and social behavior. They are as prevalent in AD as cognitive impairment and develop independently during the progression of neurodegeneration. As studying NPSs in AD is clinically challenging, most AD research to date has focused on cognitive decline. In this opinion article we summarize emerging literature on the prevalence, time course, and the underlying genetic, molecular, and pathological mechanisms related to NPSs in AD. Overall, we propose that NPSs constitute a cluster of core symptoms in AD, and understanding their neurobiology can lead to a more holistic approach to AD research, paving the way for more accurate diagnostic tests and personalized treatments embracing the goals of precision medicine.</p>","PeriodicalId":23263,"journal":{"name":"Trends in molecular medicine","volume":" ","pages":"713-722"},"PeriodicalIF":12.8000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329360/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in molecular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.molmed.2024.04.016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Neuropsychiatric symptoms (NPSs) in Alzheimer's disease (AD) constitute multifaceted behavioral manifestations that reflect processes of emotional regulation, thinking, and social behavior. They are as prevalent in AD as cognitive impairment and develop independently during the progression of neurodegeneration. As studying NPSs in AD is clinically challenging, most AD research to date has focused on cognitive decline. In this opinion article we summarize emerging literature on the prevalence, time course, and the underlying genetic, molecular, and pathological mechanisms related to NPSs in AD. Overall, we propose that NPSs constitute a cluster of core symptoms in AD, and understanding their neurobiology can lead to a more holistic approach to AD research, paving the way for more accurate diagnostic tests and personalized treatments embracing the goals of precision medicine.
阿尔茨海默病(AD)的神经精神症状(NPSs)是反映情绪调节、思维和社交行为过程的多方面行为表现。这些症状在阿尔茨海默病中与认知障碍一样普遍,并且在神经退行性病变的进展过程中独立发展。由于研究 AD 中的 NPSs 在临床上具有挑战性,迄今为止,大多数 AD 研究都集中在认知功能衰退方面。在这篇观点性文章中,我们总结了有关 AD 中 NPSs 的发病率、时间进程以及相关遗传、分子和病理机制的新兴文献。总之,我们认为NPSs是AD的一组核心症状,了解它们的神经生物学特性可以为AD研究提供更全面的方法,为更精确的诊断测试和个性化治疗铺平道路,从而实现精准医学的目标。
期刊介绍:
Trends in Molecular Medicine (TMM) aims to offer concise and contextualized perspectives on the latest research advancing biomedical science toward better diagnosis, treatment, and prevention of human diseases. It focuses on research at the intersection of basic biology and clinical research, covering new concepts in human biology and pathology with clear implications for diagnostics and therapy. TMM reviews bridge the gap between bench and bedside, discussing research from preclinical studies to patient-enrolled trials. The major themes include disease mechanisms, tools and technologies, diagnostics, and therapeutics, with a preference for articles relevant to multiple themes. TMM serves as a platform for discussion, pushing traditional boundaries and fostering collaboration between scientists and clinicians. The journal seeks to publish provocative and authoritative articles that are also accessible to a broad audience, inspiring new directions in molecular medicine to enhance human health.